ImmunoCAST

ImmunoCAST

From medical guidelines and best practices to educational insights on specific disease states, ImmunoCAST is a podcast dedicated to providing healthcare providers of all specialties clinically relevant, easy-to-digest episodes on allergy related topics.

New HEDIS Measures for Asthma: What Clinicians Should Know
ImmunoCAST
New HEDIS Measures for Asthma: What Clinicians Should Know

Recent Episodes

62
Oct. 12, 2026

New HEDIS Measures for Asthma: What Clinicians Should Know

New HEDIS measures are changing the expectations around asthma follow-up, creating an important opportunity for primary care providers to look beyond the exacerbation itself. This episode explores the 2026 HEDIS Follow-Up After Acute and Urgent Care Visits for Asthma (AAF-E) measure and what clinicians should consider assessing during that critical 30-day follow-up. We discuss asthma control, medication adherence and inhaler technique, environmental and allergic triggers, specific IgE testing, a
61
Sept. 21, 2026

When Food Allergy Meets Food Insecurity

More than 1 in 4 children with food allergy live in food-insecure families, highlighting a challenge that extends well beyond allergen avoidance. This episode explores how food insecurity, socioeconomic status, access to care, insurance coverage, geographic barriers, medication affordability, and access to allergen-free foods can affect food allergy management and quality of life. The conversation covers diagnostic accuracy, unnecessary elimination diets, targeted specific IgE testing, testing w
60
Aug. 25, 2026

The Microbiome and Allergy: What Primary Care Should Know

About 30% to 40% of the world’s population is affected by some form of allergic disease, making allergy a routine consideration in primary care. But as interest in the microbiome grows, clinicians and patients face an important question: what does the evidence actually tell us about its role in allergic disease? This episode explores immune development, the hygiene and biodiversity hypotheses, food allergy, early-life tolerance, the gut-skin axis, atopic dermatitis, asthma, allergic rhinitis, an
59
Aug. 5, 2026

Closing the Lab-to-Clinic Gap in Allergy and Autoimmunity (ft. Dr. Zachary Rubin & Dr. Crista Prates)

Many diagnoses involve laboratory diagnostics, yet patients with autoimmune and allergic disease still face delayed or incomplete testing. In this live recording of ImmunoCAST from Lab Week 2026, featuring allergist Dr. Zachary Rubin and autoimmune specialist Dr. Crista Prates, we examine how laboratories can close the gap with smarter clinician partnerships, reflex and tiered testing, ANA follow-up strategies, anti-CCP and rheumatoid factor interpretation, and comprehensive aeroallergen and foo
58
July 21, 2026

Early-Life Allergy Risk, Precision Diagnostics, and the Future of Prevention (ft. Dr. Anna Asarnoj)

A 7% sensitization rate by 3 months of age highlights how early allergic disease can begin, making early recognition critical for long-term patient outcomes. In this episode, internationally recognized allergy researcher and pediatric allergist Dr. Anna Asarnoj shares insights from the landmark BAMSE birth cohort and her decades of research on how allergies develop, evolve, and sometimes resolve over time. Together, we explore the atopic march, early-life sensitization, component-resolved diagno
57
June 30, 2026

Behind the Discovery of Alpha-Gal Syndrome and Other Pioneering Research with Dr. Thomas Platts-Mills

Few scientists have shaped modern allergy medicine as profoundly as Dr. Thomas Platts-Mills. From pioneering research on dust mite allergens and environmental drivers of asthma to helping uncover the IgE-mediated mechanism behind alpha-gal syndrome, his discoveries have transformed how clinicians diagnose and manage allergic disease. In this special episode, Dr. Platts-Mills shares the stories behind some of allergy's most important breakthroughs, including the landmark studies that established